塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/08/27 | 1,141 | 1,146 | 1,134 | 1,134 | ±0 | ±0% | 839,300 |
2012/08/24 | 1,132 | 1,139 | 1,127 | 1,134 | -8 | -0.7% | 889,100 |
2012/08/23 | 1,142 | 1,144 | 1,131 | 1,142 | +6 | +0.5% | 1,730,700 |
2012/08/22 | 1,110 | 1,141 | 1,104 | 1,136 | +26 | +2.3% | 2,009,600 |
2012/08/21 | 1,100 | 1,111 | 1,098 | 1,110 | +16 | +1.5% | 1,409,000 |
2012/08/20 | 1,094 | 1,102 | 1,092 | 1,094 | +2 | +0.2% | 980,500 |
2012/08/17 | 1,108 | 1,108 | 1,091 | 1,092 | -14 | -1.3% | 1,335,700 |
2012/08/16 | 1,110 | 1,111 | 1,102 | 1,106 | +2 | +0.2% | 1,062,200 |
2012/08/15 | 1,115 | 1,115 | 1,096 | 1,104 | ±0 | ±0% | 1,375,200 |
2012/08/14 | 1,097 | 1,104 | 1,085 | 1,104 | +8 | +0.7% | 1,753,000 |
2012/08/13 | 1,094 | 1,103 | 1,093 | 1,096 | +5 | +0.5% | 722,100 |
2012/08/10 | 1,086 | 1,102 | 1,086 | 1,091 | -9 | -0.8% | 1,060,300 |
2012/08/09 | 1,092 | 1,104 | 1,083 | 1,100 | -2 | -0.2% | 1,622,800 |
2012/08/08 | 1,099 | 1,112 | 1,096 | 1,102 | +9 | +0.8% | 2,243,100 |
2012/08/07 | 1,090 | 1,095 | 1,083 | 1,093 | +8 | +0.7% | 1,446,700 |
2012/08/06 | 1,086 | 1,094 | 1,056 | 1,085 | +6 | +0.6% | 2,400,500 |
2012/08/03 | 1,075 | 1,081 | 1,062 | 1,079 | -25 | -2.3% | 1,989,100 |
2012/08/02 | 1,113 | 1,116 | 1,101 | 1,104 | -22 | -2% | 1,675,600 |
2012/08/01 | 1,121 | 1,137 | 1,116 | 1,126 | +8 | +0.7% | 1,523,300 |
2012/07/31 | 1,115 | 1,128 | 1,104 | 1,118 | +4 | +0.4% | 1,895,900 |
2012/07/30 | 1,104 | 1,118 | 1,093 | 1,114 | +13 | +1.2% | 1,790,600 |
2012/07/27 | 1,115 | 1,116 | 1,093 | 1,101 | -19 | -1.7% | 2,176,400 |
2012/07/26 | 1,128 | 1,128 | 1,105 | 1,120 | -9 | -0.8% | 1,342,500 |
2012/07/25 | 1,118 | 1,150 | 1,117 | 1,129 | -3 | -0.3% | 1,481,200 |
2012/07/24 | 1,146 | 1,153 | 1,130 | 1,132 | -19 | -1.7% | 1,332,100 |
2012/07/23 | 1,157 | 1,171 | 1,148 | 1,151 | -14 | -1.2% | 1,788,500 |
2012/07/20 | 1,166 | 1,202 | 1,163 | 1,165 | -29 | -2.4% | 1,912,400 |
2012/07/19 | 1,174 | 1,195 | 1,170 | 1,194 | +25 | +2.1% | 2,593,000 |
2012/07/18 | 1,164 | 1,178 | 1,157 | 1,169 | +1 | +0.1% | 2,028,400 |
2012/07/17 | 1,150 | 1,169 | 1,139 | 1,168 | +26 | +2.3% | 1,777,800 |
2012/07/13 | 1,134 | 1,145 | 1,117 | 1,142 | -7 | -0.6% | 2,699,300 |
2012/07/12 | 1,130 | 1,152 | 1,128 | 1,149 | +49 | +4.5% | 3,315,300 |
2012/07/11 | 1,109 | 1,109 | 1,094 | 1,100 | -8 | -0.7% | 964,100 |
2012/07/10 | 1,105 | 1,119 | 1,105 | 1,108 | +4 | +0.4% | 1,073,500 |
2012/07/09 | 1,087 | 1,110 | 1,084 | 1,104 | +12 | +1.1% | 1,329,900 |
2012/07/06 | 1,110 | 1,113 | 1,081 | 1,092 | -21 | -1.9% | 1,339,200 |
2012/07/05 | 1,111 | 1,116 | 1,105 | 1,113 | +3 | +0.3% | 1,226,500 |
2012/07/04 | 1,114 | 1,114 | 1,104 | 1,110 | -3 | -0.3% | 972,000 |
2012/07/03 | 1,090 | 1,114 | 1,088 | 1,113 | +19 | +1.7% | 1,179,300 |
2012/07/02 | 1,090 | 1,094 | 1,075 | 1,094 | +14 | +1.3% | 1,135,000 |
2012/06/29 | 1,059 | 1,085 | 1,057 | 1,080 | +18 | +1.7% | 1,360,400 |
2012/06/28 | 1,057 | 1,072 | 1,054 | 1,062 | +10 | +1% | 1,194,000 |
2012/06/27 | 1,059 | 1,060 | 1,047 | 1,052 | -5 | -0.5% | 1,130,700 |
2012/06/26 | 1,049 | 1,063 | 1,045 | 1,057 | +10 | +1% | 1,505,800 |
2012/06/25 | 1,060 | 1,068 | 1,044 | 1,047 | -6 | -0.6% | 919,700 |
2012/06/22 | 1,041 | 1,057 | 1,034 | 1,053 | +11 | +1.1% | 1,128,100 |
2012/06/21 | 1,026 | 1,047 | 1,026 | 1,042 | +18 | +1.8% | 1,091,900 |
2012/06/20 | 1,016 | 1,028 | 1,015 | 1,024 | +10 | +1% | 1,207,500 |
2012/06/19 | 1,016 | 1,026 | 1,012 | 1,014 | +2 | +0.2% | 1,085,700 |
2012/06/18 | 1,027 | 1,031 | 1,012 | 1,012 | +4 | +0.4% | 1,112,800 |
3101~
3150
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 235,100円 | +5.7% | +3.9% | 2.61% | 11.70倍 | 1.55倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 741,400円 | +2.2% | +10.2% | 1.62% | 14.24倍 | 1.43倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 143,100円 | +0.9% | +380.2% | 5.45% | 19.70倍 | 1.69倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 406,600円 | +1.7% | -2.9% | 3.94% | 26.68倍 | 1.40倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 209,100円 | -3.5% | -11.3% | 2.87% | 19.21倍 | 1.29倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム